TY-4028: a novel, targeted therapy for non small-cell lung cancer with EGFR exon 20 or HER2 exon 20 insertion mutations-MedSci.cn

TY-4028: a novel, targeted therapy for non small-cell lung cancer with EGFR exon 20 or HER2 exon 20 insertion mutations

Li, J; Niu, CS; Guo, ZW; Wang, H; Zheng, BL; Dou, YG; Liang, A; Ji, KG; Dong, SL; Li, MH; Zhao, YC; Zhang, YZ; Gong, AS; Liu, H; Hu, XM; Su, H; Jiang, MY; Chen, SQ; Chen, XG; Wu, YS

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务